Ratio Analysis: Unpacking Anavex Life Sciences Corporation (AVXL)’s Price-to-Cash and Price-to-Free Cash Flow

Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.

After finishing at $3.84 in the prior trading day, Anavex Life Sciences Corporation (NASDAQ: AVXL) closed at $3.71, down -3.39%. In other words, the price has decreased by -$3.39 from its previous closing price. On the day, 1.01 million shares were traded. AVXL stock price reached its highest trading level at $3.795 during the session, while it also had its lowest trading level at $3.65.


Our goal is to gain a better understanding of AVXL by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 11.85 and its Current Ratio is at 11.85. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Cantor Fitzgerald on December 06, 2022, Downgraded its rating to Neutral and sets its target price to $11 from $16 previously.

On June 23, 2022, Berenberg started tracking the stock assigning a Buy rating and target price of $40.

On September 23, 2021, BTIG Research started tracking the stock assigning a Buy rating and target price of $35.BTIG Research initiated its Buy rating on September 23, 2021, with a $35 target price.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Mar 28 ’24 when MISSLING CHRISTOPHER U sold 73,380 shares for $5.11 per share. The transaction valued at 374,972 led to the insider holds 1,250,210 shares of the business.

MISSLING CHRISTOPHER U sold 268,000 shares of AVXL for $2,139,310 on Jun 28 ’23. The President and CEO now owns 1,018,210 shares after completing the transaction at $7.98 per share.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AVXL now has a Market Capitalization of 314019968 and an Enterprise Value of 171547040.

Stock Price History:

The Beta on a monthly basis for AVXL is 0.66, which has changed by -0.5897436 over the last 52 weeks, in comparison to a change of 0.2537824 over the same period for the S&P500. Over the past 52 weeks, AVXL has reached a high of $10.45, while it has fallen to a 52-week low of $3.25. The 50-Day Moving Average of the stock is -17.81%, while the 200-Day Moving Average is calculated to be -41.64%.

Shares Statistics:

The stock has traded on average 1.27M shares per day over the past 3-months and 1082290 shares per day over the last 10 days, according to various share statistics. A total of 82.07M shares are outstanding, with a floating share count of 79.52M. Insiders hold about 3.16% of the company’s shares, while institutions hold 30.65% stake in the company. Shares short for AVXL as of 1713139200 were 22008751 with a Short Ratio of 17.30, compared to 1710460800 on 19998803. Therefore, it implies a Short% of Shares Outstanding of 22008751 and a Short% of Float of 27.68.

Earnings Estimates

The firm’s stock currently is rated by 2.0 analysts. On average, analysts expect EPS of -$0.11 for the current quarter, with a high estimate of -$0.09 and a low estimate of -$0.13, while EPS last year was -$0.17. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.09 and low estimates of -$0.15.

Analysts are recommending an EPS of between -$0.39 and -$0.57 for the fiscal current year, implying an average EPS of -$0.48. EPS for the following year is -$0.64, with 2.0 analysts recommending between -$0.41 and -$0.87.

Most Popular

[the_ad id="945"]